Back to search

Article

Highly Specific Monoclonal Antibodies Against SARS-CoV-2 Nucleocapsid Antigen for Accurate Diagnosis of COVID-19

2020-10-29

Abstract excerpt

The ongoing COVID-19 pandemic is a major global public health concern. Although rapid point of care testing for detecting viral antigen is important for management the outbreak, none of current antigen detection kits provide a reliable diagnosis due to the lack of a specific monoclonal antibody (mAb) against SARS-CoV-2. In our current study, we produced mAbs exclusively react with SARS-CoV-2 and exhibited no cros...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
37723de1-1e76-55a4-afc0-39de4d1d4959
DOI
10.2139/ssrn.3721722
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Highly Specific Monoclonal Antibodies Against SARS-CoV-2 Nucleocapsid Antigen for Accurate Diagnosis of COVID-19DOI 10.2139/ssrn.3721722
Development of Monoclonal Antibodies Against SARS-CoV-2 Nucleocapsid Protein for COVID-19 Antigen DetectionSemantic proximity
High-Specificity Targets in SARS-CoV-2 N Protein for Serological Antibody DetectionSemantic proximity
The development of a highly sensitive and quantitative SARS-CoV-2 rapid antigen test applying newly developed monoclonal antibodies to an automated chemiluminescent flow-through membrane immunoassay deviceSemantic proximity
In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19Semantic proximity
In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19Semantic proximity
Development of Nucleocapsid-Specific Monoclonal Antibodies for SARS-CoV-2 and Their ELISA Diagnostics on an Automatic Microfluidic DeviceSemantic proximity
Preparation of highly specific monoclonal antibodies against SARS-CoV-2 nucleocapsid protein and the preliminary development of antigen detection test strips.Semantic proximity
Analysis of the full genome sequences of SARS-CoV-2 isolates to determine antigenic proteins and epitopes to be used for the development of a vaccine or a diagnostic approach for COVID-19Semantic proximity
Current review on SARS-CoV-2 scientific knowledgeSemantic proximity
SARS-CoV-2 antibody responses determine disease severity in COVID-19 infected individualsSemantic proximity
A comprehensive antigen production and characterization study for easy-to-implement, highly specific and quantitative SARS-CoV-2 antibody assaysSemantic proximity
Serological diagnostic kit of SARS-CoV-2 antibodies using CHO-expressed full-length SARS-CoV-2 S1 proteinsSemantic proximity
Select a neighboring publication to make it the new centre.